A coalition of advocacy groups is asking public officials to dedicate opioid settlement funds to the treatment of people with substance abuse issues. During the opioid crisis, some 2,600 lawsuits have been filed against drug companies. (STAT)

ATAI Life Sciences is partnering with Mass General to expand its research on psychedelics for mental health treatment. ATAI will be the first partner to join Mass General’s new Center for Neuroscience of Psychedelics. (Endpoints News)

Drug-resistant infections have increased in hospitals in the wake of COVID-19, health experts said. “Seeing the world as a one-pathogen world is really problematic,” Dr. Susan Huang said. (The New York Times)

Federal health agencies will study the effectiveness of COVID-19 vaccines on variant strains, Dr. Anthony Fauci said Wednesday. The Centers for Disease Control and Prevention and the National Institutes of Health will take part in the effort. (CNBC Weekly)

The U.S. has distributed 47.2 million doses of COVID-19 vaccines but only 24.6 million doses have been administered, according to the CDC. Nearly three million of those doses have been given in long-term care facilities. (Reuters)